03:45 , Apr 13, 2018 |  BC Innovations  |  Targets & Mechanisms

Meeting the burden

A major theme at this year’s AACR is the abundance of preclinical discovery driven by molecular signatures in patient samples, suggesting the research community is heeding the call for studies better grounded in human data,...
07:00 , Mar 24, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Heat shock 70kDa protein 9 (HspA9; mortalin-2)

Cancer INDICATION: Cancer Patient sample and cell studies suggest inhibiting HspA9 could help treat cancer. HspA9 levels were higher in tumor samples from patients with breast cancer, squamous lung cell carcinoma, papillary renal cell carcinoma...
07:00 , Jun 12, 2014 |  BC Innovations  |  Strategy

CQDM: Canada on the brain

The Quebec Consortium for Drug Discovery and Brain Canada have announced at least C$10 million (US$9.2 million) in funding for a new program to develop tools to accelerate the discovery of neurological disease therapies. Under...